Entheon Biomedical Corp at Benzinga Global Small Cap Investor Conference (Virtual) Transcript
Let's bring on our next speaker. I see him working backstage. There he is. Timothy Ko, the CEO of Entheon Biomedical, ticker ENTBF here in the US. Timothy, how are we doing today?
Absolutely fantastic, a pleasure to be here.
Fantastic, a pleasure to have you on. I see your slides. Let's roll, man, the floor is yours.
Okay, wonderful. Yes, so I'm Timothy Ko. I'm the CEO of Entheon Biomedical. We're developing a new dimension in addiction treatment. There's the disclaimer language there. So yes, we're developing a personalized system of medicine within the emerging psychedelic therapy industry. Our intention here is to increase the safety and precision in psychedelic therapy using DMT and diagnostic tools.
So at Entheon, we're powered by an unwavering
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |